Lorna Knight, Associate Doctor at Canada’s Medical Clinic, shared a post on LinkedIn:
“The cure exists. The access does not.
One of the most remarkable stories in medicine today is unfolding in sickle cell disease.
For decades, treatment focused on managing symptoms, reducing pain crises, and preventing complications.
Today, gene-editing therapies such as Casgevy have shown that a functional cure is possible for some patients.
That is extraordinary science.
But it also raises a difficult question.
Approximately 75% of people born with Sickle Cell Disease are born in sub-Saharan Africa.
Yet the patients most likely to access these advanced therapies are in high-income countries